| 000 | 01164 a2200337 4500 | ||
|---|---|---|---|
| 005 | 20250514013440.0 | ||
| 264 | 0 | _c20020307 | |
| 008 | 200203s 0 0 eng d | ||
| 022 | _a1040-8401 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHobeika, A C | |
| 245 | 0 | 0 |
_aQuantitating therapeutically relevant T-cell responses to cancer vaccines. _h[electronic resource] |
| 260 |
_bCritical reviews in immunology _c2001 |
||
| 300 |
_a287-97 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aCancer Vaccines _ximmunology |
| 650 | 0 | 4 |
_aCytokines _xanalysis |
| 650 | 0 | 4 | _aCytotoxicity Tests, Immunologic |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aFlow Cytometry |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aHypersensitivity, Delayed |
| 650 | 0 | 4 | _aLymphocyte Activation |
| 650 | 0 | 4 |
_aRNA, Messenger _xanalysis |
| 650 | 0 | 4 |
_aT-Lymphocytes _ximmunology |
| 700 | 1 | _aClay, T M | |
| 700 | 1 | _aMosca, P J | |
| 700 | 1 | _aLyerly, H K | |
| 700 | 1 | _aMorse, M A | |
| 773 | 0 |
_tCritical reviews in immunology _gvol. 21 _gno. 1-3 _gp. 287-97 |
|
| 999 |
_c11561019 _d11561019 |
||